Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells

doi:10.1084/jem.171.5.1791

This Article

	Full Text (PDF, 451K)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Tremblay, M.
	Articles by Wainberg, M. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Tremblay, M.
	Articles by Wainberg, M. A.


Social Bookmarking

	What's this?

ARTICLES

Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells

M Tremblay, S Meloche, RP Sekaly and MA Wainberg
Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

Although the CD4 glycoprotein is the primary receptor for HIV-1, recent reports have suggested that other molecules might be involved in the enhancement of HIV-1 infection. We investigated the possible role of the complement receptor 2 in enhancement of HIV-1 infection in CD4+ EBV- containing B cells by infecting such cells in the presence of sera from HIV sero-positive donors, with or without added human complement. A marked increase in production of viral p24 and infectious progeny virus was observed only when infection had been carried out in the presence of human complement. The addition of mAb to the human complement receptor 2 completely inhibited this enhancement. This mechanism was CD4 dependent, suggesting a cooperative effect between these two ligands in the potentiation of viral entry.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Meyer, K., Ait-Goughoulte, M., Keck, Z.-Y., Foung, S., Ray, R. (2008). Antibody-Dependent Enhancement of Hepatitis C Virus Infection. J. Virol. 82: 2140-2149 [Abstract] [Full Text]
Subbramanian, R. A., Xu, J., Toma, E., Morisset, R., Cohen, E. A., Menezes,, J., Ahmad, A. (2002). Comparison of Human Immunodeficiency Virus (HIV)-Specific Infection-Enhancing and -Inhibiting Antibodies in AIDS Patients. J. Clin. Microbiol. 40: 2141-2146 [Abstract] [Full Text]
Tacnet-Delorme, P., Boyer, V., Thielens, N. M., Hernandez, J.-F., Bally, I., Sim, R. B., Desgranges, C., Arlaud, G. J. (1999). In Vitro Analysis of Complement-Dependent HIV-1 Cell Infection Using a Model System. J. Immunol. 162: 4088-4093 [Abstract] [Full Text]
Cantin, R., Fortin, J.-F., Lamontagne, G., Tremblay, M. (1997). The Acquisition of Host-Derived Major Histocompatibility Complex Class II Glycoproteins by Human Immunodeficiency Virus Type 1�Accelerates the Process of Virus Entry and Infection in Human T-Lymphoid Cells. Blood 90: 1091-1100 [Abstract] [Full Text]